Introduction
The brain metastases incidence is actually increasing as there has been an improvement in overall patient survival due to more effective systemic therapy [1] [2] . Stereotactic radiosurgery (SRS) is a primary modality of treatment in patient with brain metastases and has demonstrated efficacy in several randomized trials and multicenter studies, whether performed alone or in combination with whole-brain radiation therapy (WBRT) [3] [4] [5] . SRS has been shown to be efficacious and safe for a fewer number of brain metastasis. We report an exceptional outcome in a geriatric patient with multiple brain metastases who underwent multiple courses of SRS.
Case Presentation
An 81-year-old female with medical history significant for Raynaud's syndrome, hyperparathyroidism, and essential hypertension was found to have a subscapular subcutaneous lesion in July 2013, subsequently underwent excision and pathology was reported as a metastatic adenocarcinoma with focal neuroendocrine features in the lesion; molecular marker like epidermal growth factor receptor (EGFR) was negative for mutation and there was no anaplastic lymphoma kinase (ALK) fusion. Computed tomography (CT) chest performed in Aug 2013 revealed a 10 x 18 mm right lower lobe and a separate 10 mm right lower lobe nodule with multiple sub-5 mm nodules throughout both lungs. Positron emission tomography and computed tomography (PET-CT) confirmed fluorodeoxyglucose (FDG) avidity in the right lower lobe as well as three FDG avid pleural lesions and a destructive third lumbar vertebral (L3) lesion. Magnetic resonance imaging (MRI) of the brain ( Figure 1) showed a very small lesion in left temporal region for which she underwent SRS. There was no neurological deficit since the diagnosis of the brain metastases and patient tolerated the SRS treatment fairly well with good quality of the life and with no impairment in neurocognitive function.
The patient has been doing well with stable systemic disease and good performance status with Eastern Cooperative Oncology Group (ECOG) performance score of 0.
There were a total of 12 metastatic lesions identified and treated over three years. They varied in linear size from 3 mm to 12 mm. The characteristics of the brain metastases in the form of target volume, location of the brain metastases and linear size along with radiation doses have been summarized in Table 1 . 
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Discussion
Treatment for brain metastases is challenging and the outcome depends on various factors such as the age of the patient, performance status and the number of metastases, mass affect, tumor location and neurological deficit. Extracranial metastasis and systemic disease control have been a major determinant of the overall survival of the patient with brain metastasis.
Historically, WBRT has been the standard of care for patients with multiple brain metastases but it has also been associated with neuro-cognitive effect [6] [7] .
SRS has demonstrated efficacy in several randomized trials and multicenter studies, whether performed alone or in combination with WBRT. Recently, SRS has been emerged as the preferred modality of treatment for the patient with multiple brain metastases [8] . SRS has also progressively gained favor because of its minimal impact on the delivery of systemic treatment options and it may also have synergistic effect with novel immunotherapy agents.
Our patient had multiple recurrence of brain metastases since the diagnosis and underwent a total of six courses of SRS within a span of four years. Except for patient's age (>75 years), she had fairly well controlled systemic disease, good performance status, and no neurological deficit. The patient's multiple recurrence of the brain metastases has been well controlled with stereotactic radio-surgery with good clinical outcome. In total she received local intracranial treatment with stereotactic radiosurgery for 12 lesions with no neurological deficit.
The rates of local control have been equivalent between SRS and WBRT but SRS alone has been found to have higher rates of recurrence after treatment as compared to WBRT because SRS only treats the lesion visible on MRI while WBRT also treats microscopic level metastatic disease [9] . Furthermore, overall survival is similar between WBRT and SRS versus SRS alone in randomized studies [9] . Recent studies in patients with brain metastasis have also demonstrated tumor volume as the prognostic factor to predict the clinical outcome [10] .
Conclusions
Stereotactic radiosurgery is a very effective modality of treatment for recurrent and multiple brain metastases depending on the prognostic factors of the patient. Minimal cognitive decline compared with WBRT makes SRS favorable for geriatric patients with limited cognitive capacity. However, more studies are necessary on multiple SRS courses in recurrent brain metastases to determine the neuro-cognitive effect and overall outcome of the patients.
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